You are here: Home:  CCU 3 | 2005: Michael J O’Connell, MD: Select publications


Select publications

Andre T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350(23):2343-51. Abstract

Benson AB 3rd et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004 22(16):3408-19. Abstract

Cassidy J et al. Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): Efficacy results of a phase III trial. Proc ASCO 2004;Abstract 3509.

Kemeny N et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341(27):2039-48. Abstract

Kemeny MM et al. Results of the Intergroup [Eastern Cooperative Oncology Group (ECOG) and Southwest Oncology Group (SWOG)] prospective randomized study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection for colorectal liver metastases. Proc ASCO 1999;Abstract 1012.

Wolmark N et al. A phase III trial comparing oral UFT to FULV in stage II and III carcinoma of the colon: Results of NSABP Protocol C-06. Proc ASCO 2004;Abstract 3508.

 

Table of Contents Top of Page

Home

Editor’s Note:
Is capecitabine the “AC” of
adjuvant therapy for colorectal cancer?
 
Leonard B Saltz, MD
- Select publications
 
Paulo M Hoff, MD
- Select publications
 
Michael J O’Connell, MD
- Select publications
 

Faculty Disclosures

A CME Audio Series
and Activity

Editor's office

 

Terms of Use and General Disclaimer.
Copyright © 2005 Research To Practice. All Rights Reserved.